Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA

Rima F. Khabbaz; John M. Douglas; Franklyn N. Judson; Richard A. Spiegel; Michael E. St Louis; William Whittington; Trudie M. Hartley; Michael Dale Lairmore; Jonathan E. Kaplan

Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA

Rima F. Khabbaz, John M. Douglas, Franklyn N. Judson, Richard A. Spiegel, Michael E. St Louis, William Whittington, Trudie M. Hartley, Michael Dale Lairmore, Jonathan E. Kaplan

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Serum specimens from patients attending sexually transmitted disease (STD) clinics in Denver and several southeastern US cities were tested for antibody to human T-lymphotropic virus type I or II (HTLV-I/II). In Denver, 8 (2.1%) of 384 patients with a history of intravenous (IV) drug use, versus none of 201 non-IV-drug users, were HTLV-I/II seropositive. Only 2 (0.18%) of 1095 STD clinic patients from the southeastern USA had antibodies to HTLV-I/II. These data document a low prevalence of HTLV-I/II in STD clinic patients from the southeastern USA and confirm that IV drug use is an important risk factor for HTLV-I/II in the USA.

Original language	English (US)
Pages (from-to)	241-244
Number of pages	4
Journal	Journal of Infectious Diseases
Volume	162
Issue number	1
State	Published - Jul 1990
Externally published	Yes

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health
Immunology

Fingerprint Dive into the research topics of 'Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA'. Together they form a unique fingerprint.

Cite this

Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA. / Khabbaz, Rima F.; Douglas, John M.; Judson, Franklyn N.; Spiegel, Richard A.; St Louis, Michael E.; Whittington, William; Hartley, Trudie M.; Lairmore, Michael Dale; Kaplan, Jonathan E.

In: Journal of Infectious Diseases, Vol. 162, No. 1, 07.1990, p. 241-244.

Research output: Contribution to journal › Article › peer-review

Khabbaz, Rima F. ; Douglas, John M. ; Judson, Franklyn N. ; Spiegel, Richard A. ; St Louis, Michael E. ; Whittington, William ; Hartley, Trudie M. ; Lairmore, Michael Dale ; Kaplan, Jonathan E. / Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA. In: Journal of Infectious Diseases. 1990 ; Vol. 162, No. 1. pp. 241-244.

@article{72bc10cc80ba42d99607255ce4952b51,

title = "Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA",

abstract = "Serum specimens from patients attending sexually transmitted disease (STD) clinics in Denver and several southeastern US cities were tested for antibody to human T-lymphotropic virus type I or II (HTLV-I/II). In Denver, 8 (2.1%) of 384 patients with a history of intravenous (IV) drug use, versus none of 201 non-IV-drug users, were HTLV-I/II seropositive. Only 2 (0.18%) of 1095 STD clinic patients from the southeastern USA had antibodies to HTLV-I/II. These data document a low prevalence of HTLV-I/II in STD clinic patients from the southeastern USA and confirm that IV drug use is an important risk factor for HTLV-I/II in the USA.",

author = "Khabbaz, {Rima F.} and Douglas, {John M.} and Judson, {Franklyn N.} and Spiegel, {Richard A.} and {St Louis}, {Michael E.} and William Whittington and Hartley, {Trudie M.} and Lairmore, {Michael Dale} and Kaplan, {Jonathan E.}",

year = "1990",

month = jul,

language = "English (US)",

volume = "162",

pages = "241--244",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA

AU - Khabbaz, Rima F.

AU - Douglas, John M.

AU - Judson, Franklyn N.

AU - Spiegel, Richard A.

AU - St Louis, Michael E.

AU - Whittington, William

AU - Hartley, Trudie M.

AU - Lairmore, Michael Dale

AU - Kaplan, Jonathan E.

PY - 1990/7

Y1 - 1990/7

N2 - Serum specimens from patients attending sexually transmitted disease (STD) clinics in Denver and several southeastern US cities were tested for antibody to human T-lymphotropic virus type I or II (HTLV-I/II). In Denver, 8 (2.1%) of 384 patients with a history of intravenous (IV) drug use, versus none of 201 non-IV-drug users, were HTLV-I/II seropositive. Only 2 (0.18%) of 1095 STD clinic patients from the southeastern USA had antibodies to HTLV-I/II. These data document a low prevalence of HTLV-I/II in STD clinic patients from the southeastern USA and confirm that IV drug use is an important risk factor for HTLV-I/II in the USA.

AB - Serum specimens from patients attending sexually transmitted disease (STD) clinics in Denver and several southeastern US cities were tested for antibody to human T-lymphotropic virus type I or II (HTLV-I/II). In Denver, 8 (2.1%) of 384 patients with a history of intravenous (IV) drug use, versus none of 201 non-IV-drug users, were HTLV-I/II seropositive. Only 2 (0.18%) of 1095 STD clinic patients from the southeastern USA had antibodies to HTLV-I/II. These data document a low prevalence of HTLV-I/II in STD clinic patients from the southeastern USA and confirm that IV drug use is an important risk factor for HTLV-I/II in the USA.

UR - http://www.scopus.com/inward/record.url?scp=0025293584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025293584&partnerID=8YFLogxK

M3 - Article

C2 - 2192006

AN - SCOPUS:0025293584

VL - 162

SP - 241

EP - 244

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -